Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10007053HBVENSG00000128052.10protein_codingKDRYesNo3791P35968
TVIS10007054HBVENSG00000128052.10protein_codingKDRYesNo3791P35968
TVIS10016656HBVENSG00000128052.10protein_codingKDRYesNo3791P35968
TVIS10000123HBVENSG00000128052.10protein_codingKDRYesNo3791P35968
TVIS20058066HPVENSG00000128052.10protein_codingKDRYesNo3791P35968
TVIS44025335HTLV-1ENSG00000128052.10protein_codingKDRYesNo3791P35968
TCGA Plot Options
Drug Information
GeneKDR
DrugBank IDDB08901
Drug NamePonatinib
Target IDBE0000369
UniProt IDP35968
Regulation Typeinhibitor
PubMed IDs19878872
CitationsO'Hare T, Shakespeare WC, Zhu X, Eide CA, Rivera VM, Wang F, Adrian LT, Zhou T, Huang WS, Xu Q, Metcalf CA 3rd, Tyner JW, Loriaux MM, Corbin AS, Wardwell S, Ning Y, Keats JA, Wang Y, Sundaramoorthi R, Thomas M, Zhou D, Snodgrass J, Commodore L, Sawyer TK, Dalgarno DC, Deininger MW, Druker BJ, Clackson T: AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell. 2009 Nov 6;16(5):401-12. doi: 10.1016/j.ccr.2009.09.028.
GroupsApproved; Investigational
Direct ClassificationBenzanilides
SMILESCN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
PathwaysPonatinib Inhibition of BCR-ABL
PharmGKBPA165980594
ChEMBLCHEMBL1171837